BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference

  ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 11:30 a.m. ET.

  May 30, 2024

   · 

  4 min read
• Bio NC

  Humacyte to Present at the Jefferies Global Healthcare Conference

  Humacyte, Inc. today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference, in New York, NY on Thursday, June 6, 2024.

  May 30, 2024

   · 

  2 min read
• Genetown

  Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

  Corbus Pharmaceuticals Holdings, Inc. today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and participate in one-on-one investor meetings at the 45th Annual Goldman Sachs Global Healthcare Conference to be held June 10-13, 2024 in Miami Beach, FL.

  May 30, 2024

   · 

  3 min read
• Business

  Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases

  Evotec SE announced that the Company entered a partnership with Inserm, the French National Institute of Health and Medical Research, Lille University Hospital and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases.

  May 30, 2024

   · 

  11 min read
• Medivir to present at Redeye Growth Day

  Medivir AB announces that the company will participate at Redeye Growth Day, today May 30, 2024.

  May 30, 2024

   · 

  1 min read
• Business

  Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

  Anocca AB and Shinobi Therapeutics announced a strategic partnership to use Shinobi’s proprietary immune evasive iPS-T cell platform with novel candidate TCRs, discovered and validated by Anocca, to develop a new class of off-the-shelf allogeneic TCR engineered iPS-T-cell therapies for solid tumors.

  May 30, 2024

   · 

  4 min read
• Biotech Beach

  BIO 2024 Sets the Stage for Taiwan’s Biotech Industry to Shine

  The 2024 edition of BIO International Convention 2024, the world’s largest and most comprehensive global biotech event, will be held from June 3 to 6 at San Diego Convention Center, San Diego, California.

  May 30, 2024

   · 

  5 min read
• GlycoNex to Participate in 2024 BIO International Convention

  GlycoNex, Inc. announced its participation in this year’s BIO International Convention, which is being held in San Diego, CA, June 3-6, 2024.

  May 30, 2024

   · 

  1 min read
• Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders

  RELIEF THERAPEUTICS Holding SA announced the Annual General Meeting of shareholders will take place on Thursday, June 27, 2024, at 11:00 a.m. CEST at Campus Biotech, chemin des Mines 9, 1202 Geneva, Switzerland.

  May 30, 2024

   · 

  3 min read
• Genflow Biosciences PLC Announces Receipt of Grant Funding

  Genflow Biosciences Plc is pleased to announce receipt of 50% of its substantial non-diluting and non-reimbursable research grant.

  May 30, 2024

   · 

  6 min read